Search Results - J. Gotlib

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA by A. Kuykendall, M. Kremyanskaya, Y. Ginsburg, N. Pemmaraju, E. Ritchie, J. Gotlib, F. Valone, S. Khanna, S. Gupta, R. Hoffman, S. Verstovsek

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P1038: CLINICOPATHOLOGIC AND MOLECULAR CORRELATES OF ORGAN DAMAGE ACROSS THE SPECTRUM OF ADVANCED SYSTEMIC MASTOCYTOSIS by E. Liang, C. Perkins, R. Lu, H. Shi, S. Dimitrijevic, G. Hoehn, J. Abuel, C. Langford, P. Abidi, L. Fechter, W. Shomali, J. Gotlib

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    C018 | OVERALL SURVIVAL AND DURATION OF TREATMENT IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR BEST AVAILABLE THERAPY IN A REAL-WORLD... by A. M. Vannucchi, A. Reiter, J. Gotlib, I. Álvarez-Twose, D. H. Radia, J. Luebke, P. J. Bobbili, A. Wang, S. Dimitrijević, E. Sullivan, J. Schwaab, I. A. Galinsky, C. Perkins, W. R. Sperr, P. Sriskandarajah, M. Mohan, T. Badu, M. S. Duh, P. Valent

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  4. 4

    P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE by A. Reiter, J. Gotlib, I. Álvarez-Twose, D. H. Radia, J. Luebke, P. J. Bobbili, A. Wang, C. Norregaard, S. Dimitrijević, E. Sullivan, M. Louie-Gao, J. Schwaab, I. A. Galinsky, C. Perkins, W. R. Sperr, P. Sriskandarajah, A. Chin, S. R. Sendhil, M. S. Duh, P. Valent, D. J. DeAngelo

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY by A. Reiter, J. Gotlib, I. Álvarez-Twose, D. H. Radia, J. Luebke, P. J. Bobbili, A. Wang, C. Norregaard, S. Dimitrijević, E. Sullivan, M. Louie-Gao, J. Schwaab, I. A. Galinsky, C. Perkins, W. R. Sperr, P. Sriskandarajah, A. Chin, S. R. Sendhil, M. S. Duh, P. Valent, D. J. DeAngelo

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY by A. Reiter, J. Gotlib, I. Álvarez-Twose, D. H. Radia, J. Luebke, P. J. Bobbili, A. Wang, C. Norregaard, S. Dimitrijević, E. Sullivan, M. Louie-Gao, J. Schwaab, I. A. Galinsky, C. Perkins, W. R. Sperr, P. Sriskandarajah, A. Chin, S. R. Sendhil, M. S. Duh, P. Valent, D. J. DeAngelo

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    C016 | GENOMIC PROFILING FOR CLINICAL DECISION MAKING IN POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS. by B. Mora, P. Guglielmelli, A. Kuykendall, M. Maffioli, F. Palandri, A. Iurlo, V. De Stefano, S. Salmoiraghi, T. Devos, F. Itri, F. Cervantes, J-J. Kiladjian, M.G. Della Porta, F. Albano, J. Gotlib, G. Benevolo, M. Caramella, M. Ruggeri, E. Rumi, D. M. Ross, C. Pessina, I. Colugnat, F. Orsini, G. Rotunno, R.S. Komrokji, D. Cattaneo, T. Barbui, D. Cilloni, L. Margotto, M. Franchi, A.M. Vannucchi, F. Passamonti

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  8. 8

    P995: MYELOID NEOPLASMS-ASSOCIATED GENE VARIANTS IN 639 PATIENTS WITH POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: AN ANALYSIS OF THE MYSEC COHORT by B. Mora, P. Guglielmelli, A. Kuykendall, M. Maffioli, G. Rotunno, R. S. Komrokji, F. Palandri, J.-J. Kiladjian, A. Iurlo, G. Auteri, D. Cattaneo, V. De Stefano, S. Salmoiraghi, T. Devos, F. Cervantes, M. Merli, A. Campagna, G. Benevolo, M. Brociner, F. Albano, J. Gotlib, M. Caramella, M. Ruggeri, D. M. Ross, F. Orsini, C. Pessina, I. Colugnat, F. Pallotti, T. Barbui, L. Bertù, M. G. Della Porta, A. M. Vannucchi, F. Passamonti

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: